Comparison of different treatment modalities of tocilizumab in children with systemic juvenile idiopathic arthritis

Comparison of different treatment modalities of tocilizumab in children with systemic juvenile idiopathic arthritis

Aim: to perform retrospective evaluation of tocilizumab (TCZ) treatment every 2 and 4 weeks. Patients and methods: 33 children with systemic juvenile idiopathic arthritis (sJIA) were observed. Results: children, who need TCZ treatment every 2 weeks had more severe sJIA course. Patients which were tr...

Full description

Bibliographic Details
Main Authors: M. M. Kostik, M. F. Dubko, L. S. Snegireva, V. V. Masalova, T. L. Kornishina, T. S. Likhacheva, I. A. Chikova, E. A. Isupova, E. M. Kuchinskaya, N. I. Glebova, O. V. Kalashnikova, V. G. Chasnykh
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2013-09-01
Series:Вопросы современной педиатрии
Subjects:
дети
системный ювенильный идиопатический артрит
интерлейкин 6
тоцилизумаб
Online Access:https://vsp.spr-journal.ru/jour/article/view/275

Internet

https://vsp.spr-journal.ru/jour/article/view/275

Similar Items